We are close to the first drug treatment of the disorder of sexual arousal in women?
Today we have the first signs of a promising drug therapy apefthyne- shall be women with sexual arousal difficulty.
This is the alprostadil substance, which is coated with cream to female genitalia. The pharmaceutical substance has vasodilatory properties that increase blood flow to the vaginal area. At the European Society Congress of Sexual Medicine at sterntam AM-2012, presented the first data based on 400 women diagnosed with sexual arousal disorder.
According to researchers, the intravaginal use of alprostadil significantly improved ygran- importance of the genitals, the stimulating sensation and sexual desire.
What is included in treatments of the disorder of sexual arousal in women today?
To date, the treatment of sexual arousal in women was primarily psychose- xoualiki therapy. Relevant techniques include education of women, to increase the sexual stimulation and to be able to focus on them, improving sexual partner skills and techniques gradually increase sexual closeness of the couple.
Because in each case, we are interested in both the stimulation of the genitals (eg vaginal blood supply or lubrication) and the subjective feeling of pleasure, we hope that in the future there will be possibilities to combine pharmaceutical and psychosexual therapy.
